Athersys CEO BJ Lehmann , Axogen EVP and CFO Peter Mariani, and I gathered for a regenerative medicine roundtable discussion in advance of the 2022 JP Morgan Healthcare Conference.
- A “year of firsts and records” for the regenerative medicine sector
- Challenges in developing stem cells and other regenerative medicine approaches today, and how they are being addressed
- Advantages of allogeneic therapies
- What the next decade will bring
The HealthBiz podcast is available on Spotify, Apple Podcasts, Google Podcasts, YouTube and many more services.
By healthcare business consultant David E. Williams, president of Health Business Group.
January 13, 2022